>> 2005
>> 2004
>> 2003
|
| DATE |
|
TITLE |
 |
| 2005 |
|
| March 3, 2005 |
|
ASPREVA PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AT US$11.00 (C$13.68) PER SHARE |
| February 17, 2005 |
|
TA ASSOCIATES COMPLETES MINORITY INVESTMENT IN MICROBAN INTERNATIONAL |
|
| 2004 |
|
| December 10, 2004 |
|
Adeza Biomedical Corporation Announces Initial Public Offering of Common Stock |
| September 24, 2004 |
|
Sprout Group Announces $12M Financing in Sopherion Therapeutics |
| July 28, 2004 |
|
Workstream Completes Acquisition of Bravanta to Strengthen Compensation Offerings |
| July 15, 2004 |
|
Phase Forward Incorporated Announces Pricing of Initial Public Offering |
| June 8, 2004 |
|
St. Jude Medical Completes Acquisition of Epicor Medical, Inc. |
| June 7, 2004 |
|
Corixa and GlaxoSmithKline announce results of two studies of BEXXAR® following chemotherapy as first-line treatment... |
| June 7, 2004 |
|
ISTA Pharmaceuticals Receives FDA Approval for ISTALOLTM for the Treatment of Glaucoma |
| June 5, 2004 |
|
Nuvelo Announces Preliminary Phase 2 Alfimeprase Results in Acute Peripheral Arterial Occlusion... |
| March 9, 2004 |
|
ASPREVA PHARMACEUTICALS COMPLETES FIRST-ROUND PRIVATE EQUITY FINANCING, RAISING US$57 MILLION |
| February 3, 2004 |
|
METABASIS THERAPEUTICS, INC. FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING OF COMMON STOCK |
| January 13, 2004 |
|
METABASIS THERAPEUTICS AND MERCK ANNOUNCE A COLLABORATION |
| January 9, 2004 |
|
SPROUT GROUP NAMES ANDREW D. FIRLIK VENTURE PARTNER |
| January 6, 2004 |
|
SPIRATION SUCCESSFULLY CLOSES $26.9 MILLION SERIES E FINANCING;
INVESTMENT TO PREPARE FOR MARKET LAUNCH OF MEDICAL DEVICES FOR PULMONARY CARE |
|
| 2003 |
|
| December 18, 2003 |
|
ISTA PHARMACEUTICALS ANNOUNCES ACHIEVEMENT OF PHASE III PATIENT ENROLLMENT GOAL FOR XIBROM NDA FILING ANTICIPATED IN EARLY 2004 |
| November 19, 2003 |
|
ISTA PHARMACEUTICALS PRESENTS VITRASE PHASE III DATA AT AMERICAN ACADEMT OF OPHTHALMOLOGY ANNUAL MEETING |
| November 18, 2003 |
|
ADEZA BIOMEDICAL SHIPS 1,000TH SYSTEM
COMPANY NAMED SILICON VALLEY GROWTH LEADER |
| November 6, 2003 |
|
AUXILIUM COMPLETES $43 MILLION PRIVATE FINANCING |
| November 5, 2003 |
|
FDA ACCEPTS SECOND VITRASE NDA ISTA PHARMACEUTICALS, INC. |
| November 3, 2003 |
|
FOCUS ANNOUNCES FDA CLEARANCE OF WEST NILE VIRUS IGG |
| October 28, 2003 |
|
METABASIS THERAPEUTICS, INC. COMPLETES FINANCING |
| October 11, 2003 |
|
XCYTE THERAPIES REVIVES IPO PLAN |
| September 23, 2003 |
|
ADOLOR CORPORATION ANNOUNCES POSITIVE TOP-LINE RESULTS IN 2ND PHASE 3 STUDY OF ALVIMOPAN IN POSTOPERATIVE ILEUS |
| September 19, 2003 |
|
BLUE COAT RAISES $13 MILLION IN PRIVATE FINANCING WITH SPROUT GROUP |
| September 19, 2003 |
|
CONCUR TECHNOLOGIES NAMED TO DELOITTE & TOUCHE TECHNOLOGY |
| September 18, 2003 |
|
PROMETHEUS LABORATORIES RANKS FOURTH ON DELOITTE & TOUCHE'S PRESTIGIOUS TECHNOLOGY FAST 50 PROGRAM |
| September 17, 2003 |
|
SPROUT GROUP LEADS INVESTMENT OF $10 MILLION IN INTERCEPT, INC. |
| September 16, 2003 |
|
SIRNA TO PRESENT PROGRESS IN ITS MACULAR DEGENERATION PROGRAM AT THE NUCLEIC ACID WORLD SUMMIT |
| August 6, 2003 |
|
ALCATEL ANNOUNCES AN OEM AGREEMENT WITH WATERCOVE NETWORKS STRENGTHENING MOBILE SOLUTIONS PORTFOLIO FOR DELIVERY OF BILLABLE INTERNET SERVICES |
| July 21, 2003 |
|
MORE PHYSICIANS HOLD LIVES IN THE PALMS OF THEIR HANDS |
| June 30, 2003 |
|
CORIXA AND GLAXOSMITHKLINE ANNOUNCE FDA APPROVAL OF BEXXAR® |
| June 23, 2003 |
|
AFFYMAX APPOINTS ARLENE MORRIS PRESIDENT AND CHIEF EXECUTIVE OFFICER AND COMPLETES $20 MILLION FINANCING |
| June 13, 2003 |
|
CORIXA ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED FINANCINGS |
| May 21, 2003 |
|
EVOLUTION BENEFITS SECURES $5.5 MILLION IN FINANCING |
| May 12, 2003 |
|
SYMYX TECHNOLOGIES ANNOUNCES LAUNCH OF SYMYX THERAPEUTICS, INC. |
| May 5, 2003 |
|
FOCUS TECHNOLOGIES OFFERS FIRST COMMERCIAL LABORATORY TEST FOR SEVERE ACUTE RESPIRATORY SYNDROME (SARS) |
| May 2, 2003 |
|
ST. JUDE MEDICAL ANNOUNCES INVESTMENT IN EPICOR MEDICAL, INC. |
| April 24, 2003 |
|
SPROUT GROUP ANNOUNCES COMPLETION OF $24 MILLION INVESTMENT IN SIRNA THERAPEUTICS |
| April 21, 2003 |
|
STRUCTURAL GENOMIX FORMS RESEARCH AND TECHNOLOGY COLLABORATION WITH LILLY TO AID DRUG DISCOVERY |
| March 25, 2003 |
|
KALYPSYS TO PROVIDE MERCK WITH NEXT-GEN. LEAD DISCOVERY |
| March 17, 2003 |
|
RADIANT MEDICAL ANNOUNCES DATA FROM ENDOVASCULAR COOLING TRIAL |
| February 12, 2003 |
|
RIBOZYME PHARMACEUTICALS SIGNS AGREEMENT TO SECURE $48 MILLION IN FINANCING |
| February 3, 2003 |
|
HYSEQ AND VARIAGENICS MERGE TO FORM NEW COMPANY |
| January 30, 2003 |
|
KEITH GEESLIN NAMED TO THE FORBES 2003 MIDAS LIST |
| January 29, 2003 |
|
DEPUY, INC. ACQUIRES CERTAIN ASSETS OF ORQUEST, INC. FURTHER EXPANDS ORTHOBIOLOGIC PRODUCT PORTFOLIO AND PIPELINE |
| January 15, 2003 |
|
PHASE FORWARD SELECTED BY BIOGEN TO PROVIDE WORLDWIDE CLINICAL DATA SOLUTION |
| January 09, 2003 |
|
PROMETHEUS LABORATORIES ANNOUNCES KEY SENIOR EXECUTIVE APPOINTMENTS |
| January 08, 2003 |
|
TOLERRX ANNOUNCES THE APPOINTMENT OF JAMES E. NIEDEL |
| January 03, 2003 |
|
TOLERRX COMPLETES $35 MILLION SERIES C FINANCING |
